Results 131 to 140 of about 6,386 (165)
Some of the next articles are maybe not open access.

Peptidomimetics in Silico

Molecular Informatics, 2020
AbstractEndogenous peptides as part of physiological processes are targets of interest when it comes to finding desirable therapeutics which are able to modulate molecular interactions. The major limits presented by peptides when they are used as drugs have motivated the research of the synthesis of peptidomimetics obtained through chemical ...
Cristina Tomasella   +4 more
openaire   +2 more sources

Peptidomimetic design

Current Opinion in Chemical Biology, 1998
Major discoveries have been made of new type-I and type-III peptidomimetic inhibitors of peptide-derived systems. Innovative reversible inhibitors of cysteine proteases and renin, and additional examples of peptidomimetic inhibitors of interleukin-1 beta-converting enzyme, neutral endopeptidase, herpes simplex virus protease, thrombin, HIV protease ...
A S, Ripka, D H, Rich
openaire   +2 more sources

Peptidomimetics and Angiogenesis

Mini-Reviews in Medicinal Chemistry, 2002
Angiogenesis is the sprouting of new blood capillaries from surrounding preexisting blood vessels. This process is fundamental for embryonic development, wound healing and inflammation. In healthy adults angiogenesis is of minor importance. However, aberrant angiogenesis is essentially involved in disorders as diabetic retinopathy, rheumatoid arthritis
Ralph, Mazitschek   +2 more
openaire   +2 more sources

Formylated polyamines as peptidomimetics

Bioorganic & Medicinal Chemistry Letters, 2012
A new construct for imitating a natural peptide ligand using a modified retro-inverso sequence is described. It is demonstrated through the synthesis of a peptidomimetic derived from the endogenous sequence of leucine enkephalin. The product was active at 400 nM and selective for μ-opioid receptors.
Sacha, Javor   +5 more
openaire   +2 more sources

Aminimides as Peptidomimetics

2003
Highly selective and specific protein-protein and peptide-protein interactions are elicited by a large number of natural specific biological responses. The mimicry of these natural interactions has been an important and useful strategy for the development of metabolically stable drugs capable of being administered orally (1-4).
B S, Fulton   +3 more
openaire   +2 more sources

Novel peptidomimetic hematoregulatory compounds

Bioorganic & Medicinal Chemistry Letters, 2000
The activity of a novel series of peptidomimetic hematoregulatory compounds, designed based on a pharmacophore model inferred from the structure activity relationships of a peptide SK&F 107647 (1), is reported. These compounds induce a hematopoietic synergistic factor (HSF) which in turn modulates host defense.
D A, Heerding   +11 more
openaire   +2 more sources

Minimalist and universal peptidomimetics

Chemical Society Reviews, 2011
Many "new generation" peptidomimetics are designed to present amino acid side chains only; they do not have structural features that resemble peptide main chains. These types of molecules have frequently been presented in the literature as mimics of specific secondary structures.
Eunhwa, Ko, Jing, Liu, Kevin, Burgess
openaire   +2 more sources

Peptidomimetics in cancer chemotherapy

Clinical and Translational Oncology, 2007
A summary of the current status of the application of peptidomimetics in cancer therapeutics as an alternative to peptide drugs is provided. Only compounds that are used in therapy or at least under clinical trials are discussed, using inhibitors of farnesyltransferase, proteasome and matrix metalloproteinases as examples.
C, Avendaño, J C, Menéndez
openaire   +2 more sources

Steroid Receptor Coactivator Peptidomimetics

2003
Publisher Summary This chapter focuses on the methods that are useful for designing and synthesizing a series of coactivator peptidomimetics (axXXbxcx) of the L1XXL2L3 sequence to identify specific inhibitors of particular hormone receptor (NR)–coactivator interactions.
Timothy R, Geistlinger, R Kiplin, Guy
openaire   +2 more sources

Peptidomimetics derived from natural products

Medicinal Research Reviews, 1993
Although much has been written in recent years about rational drug design, no drug has been designed de novo, that is, without using a natural substrate or inhibitor or screening lead as a starting point. Instead, as we have seen, medicinal chemists continue to depend upon serendipitous discovery of novel biological activities and novel chemical ...
R A, Wiley, D H, Rich
openaire   +2 more sources

Home - About - Disclaimer - Privacy